Action Duchenne Provides £150k For Gene Therapy Research For New Treatment For Duchenne Muscular Dystrophy

Research Scientists at Oxford University have received £150k raised by Action Duchenne to fund the latest research into ‘Exon skipping’, a gene therapy approach to treat Duchenne Muscular Dystrophy. The project forms part of the larger research programme currently being undertaken by MDEX Consortium* UK, a group of research scientists that has received over £2M of funding from the UK government and Medical Research Council (MRC) to conduct clinical trials on DMD patients.

More: continued here

Filed under: Muscular Dystrophy on September 8th, 2008